2022-RA-944-ESGO Real-world safety, baseline characteristics and first-year therapy management in patients withBRCA1/BRCA2-mutated advanced ovarian cancer treated with olaparib tablets in the first-line maintenance setting: first analysis of the pan-European OVAL-1 study

Autor:	Domenica Lorusso, Charlie Gourley, Delphine Garbay, Bernard Jean Roger Asselain, Francesco Raspagliesi, Claudio Zamagni, Alexandra Leary, Charlotte Bellier, Ros Glasspool, Gordon Jayson, Angela Whittle, Ilaria Sabatucci, Emmanuelle Grevat, Muriel Licour, Rowan Miller
Rok vydání:	2022
Zdroj:	Ovarian cancer.
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::a1a686d431285494146b77e4353581b3 https://doi.org/10.1136/ijgc-2022-esgo.600 Zobrazit plný text záznamu